Skip Navigation

European Heart Journal 1995 16(Supplement L):86-92; doi:10.1093/eurheartj/16.suppl_L.86
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Görge, G.
Right arrow Articles by Erbel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Görge, G.
Right arrow Articles by Erbel, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Scociety of Cardiology

Intravascular ultrasound: a guide for management of complications during intervention?

G. Görge, J. Ge, M. Haude, D. Baumgart, G. Caspari, R. Leischik, F. Liu and R. Erbel

Department of Cardiology, University Hospital Essen, Germany

Correspondence: G$$$nter Görge, MD, Department of Cardiology, University Hospital, Hufelandstrasse 55, D-45122 Essen, Germany

Within a few years, intravascular ultrasound (IVUS) has emerged from a research tool into an intrinsic part of modern invasive cardiology, mainly because histology can be obtained ‘in-vivo’. For the first time in invasive cardiology it is possible to base decisions not only on lumenograms but also on vessel wall assessment. IVUS can be used as both a diagnostic tool and for intervention purposes. Its diagnostic strength lies in its ability to monitor compensatory coronary artery enlargement as a response to arteriosclerosis, to reveal occult left main stem disease, and angiographically ‘silent’ arteriosclerosis. As regards intervention, IVUS aids in optimal device selection, i.e. whether to use rotablators in calcified lesions or atherectomy devices in large plaques. The effects of PTCA on vessel wall morphology can be studied in great detail and the effect on luminal gain assessed almost on-line. Several groups have shown that the residual plaque area, even after angiographically successful PTCA, is about 60%. A significant reduction in this percentage may influence long-term outcome after PTCA. Luminal areas that are minimal after PTCA seem to indicate restenosis, while morphological appearance on its own seems to be less predictive. One answer to the shortcomings of standard PTCA are coronary artery stents. Intravascular monitoring of stent expansion led to the deployment of high-pressure stents with a significant increase in post-procedural luminal diameters, and finally the ability to withhold anticoagulation in patients with optimal stent deployment. Furthermore, integrated devices, such as balloons on IVUS catheters, steerable catheters, integrated flow measurements, pressure transducers, and hopefully, tissue characterization, will further enhance the usefulness of IVUS.

Key Words: Intravascular ultrasound • PTCA • atherectomy • stents • restenosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
H. Kodama, K. Fukuda, J. Pan, S. Makino, M. Sano, T. Takahashi, S. Hori, and S. Ogawa
Biphasic Activation of the JAK/STAT Pathway by Angiotensin II in Rat Cardiomyocytes
Circ. Res., February 9, 1998; 82(2): 244 - 250.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.